Toggle light / dark theme

Chroma Scores $135M for Epigenetic Editing Approach

Posted in biotech/medical, genetics

Backed by Google Ventures, ARCH Venture Partners and more, Chroma Medicine announced the closing of a $135 million Series B financing Wednesday.